Merck KGaA Reports Results for Evobrutinib in P-III Trial for the Treatment of Relapsing Multiple Sclerosis (RMS)
December 6, 2023
Merck KGaA and Hengrui Pharma Entered into a Licensing Agreement to Develop and Commercialize HRS-1167 and SHR-A1904 to Treat Canc...
October 31, 2023
Merck KGaA Reports P-III Trial (JAVELIN Bladder 100) Results of Bavencio (avelumab) in 1L Maintenance Treatment for Advanced Uroth...
February 14, 2023
Merck KGaA Entered into Option to License Agreement with Nerviano Medical Sciences to Develop NMS-293
September 21, 2022
Top 20 BioPharma Companies based on 2021 Total Revenue
April 14, 2022
PharmaShots Weekly Snapshots (November 15 - 19, 2021)
November 19, 2021
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.